Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 4—April 2016
Dispatch

Cross-Neutralization between Human and African Bat Mumps Viruses

Hiroshi Katoh, Toru Kubota, Toshiaki Ihara, Ken Maeda, Makoto TakedaComments to Author , and Minoru Kidokoro
Author affiliations: National Institute of Infectious Diseases, Tokyo, Japan (H. Katoh, T. Kubota, M. Takeda, M. Kidokoro); Mie Hospital, Mie, Japan (T. Ihara); Yamaguchi University, Yamaguchi, Japan (K. Maeda)

Main Article

Figure 2

Comparison of the NT titer of rOdate versus rOdate/ABMuV-F (A), -HN (B), and -FHN (C) in a study of serologic cross-reactivities. r and p values, calculated by using the Pearson product-moment correlation, are as follows: (A) r = 0.67, p<0.05; (B) r = 0.77, p<0.01; (C) r = 0.71, p<0.05. ABMuV, African bat mumps virus; F, fusion; HN, hemagglutinin-neuraminidase; NT, neutralizing.

Figure 2. Comparison of the NT titer of rOdate versus rOdate/ABMuV-F (A), -HN (B), and -FHN (C) in a study of serologic cross-reactivities. r and p values, calculated by using the Pearson product-moment correlation, are as follows: (A) r = 0.67, p<0.05; (B) r = 0.77, p<0.01; (C) r = 0.71, p<0.05. ABMuV, African bat mumps virus; F, fusion; HN, hemagglutinin-neuraminidase; NT, neutralizing.

Main Article

Page created: March 16, 2016
Page updated: March 16, 2016
Page reviewed: March 16, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external